Lonza Group AG Lonza Group AG

Lonza Group AG

LONN

Kedudukan dalam Saham #445
Lonza Group AG, together with its subsidiaries, operates as a contract... Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Integrated Biologics; Advanced Synthesis; and Specialized Modalities segments. The Integrated Biologics segment offers CDMO biologics services from clinical development, drug substance, and drug product manufacturing; and operates mammalian and drug product platforms. Its Advanced Synthesis segment manufactures antibody-drug conjugates (ADCs) and other bioconjugates, small molecules, and highly potent active pharmaceutical ingredients; and operates small molecules and bioconjugates platforms. The Specialized Modalities segment operates various technologies, such as spanning cell & gene, microbial, bioscience, and mRNA. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.
Harga Saham
$763.79
Modal Pasaran
$53.35B
Perubahan (1 hari)
0.93%
Perubahan (1 tahun)
8.56%
Negara
CH
Perdagangan Lonza Group AG (LONN)

Kategori

Healthcare
Sejarah harga saham bagi Lonza Group AG (LONN)
Harga penutupan tertinggi: $758.47 pada 2026-10-01

Harga penutupan terendah: $55.45 pada 1999-11-01
Sejarah harga saham Lonza Group AG dari 1999 hingga 2026
Prestasi harga saham tahunan
Tahun Prestasi
2026 (TTM) 2.71%
2025 12.69%
2024 52.26%
2023 -21.39%
2022 -38.27%
2021 29.85%
2020 78.48%
2019 17.36%
2018 12.75%
2017 66.47%
2016 7.54%
2015 39.65%
2014 24.10%
2013 74.91%
2012 -11.33%
2011 -26.82%
2010 12.01%
2009 -13.00%
2008 -29.50%
2007 34.20%
2006 46.37%
2005 8.46%
2004 5.02%
2003 -11.00%
2002 -13.66%
2001 22.46%
2000 -6.51%
1999 0.00%
Harga saham bagi syarikat atau pesaing serupa
Syarikat Harga saham Perubahan 1thn% Negara
$534.63 25.37%
US
$211.92 689.28%
US
$137.83 -3.78%
AU
$291.76 2.51%
BE
$876.10 7.61%
NL